Powered by

Latest news

Here you can find the latest articles about the Baden-Württemberg healthcare industry.

  • Article - 13-Nov-2017

    About 30,000 artificial heart valves are implanted in Germany every year. The durability of these heart valves presents a major challenge, requiring them to be exchanged time and again, especially in young patients. Researchers from the Stuttgart Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB have developed a new artificial heart valve material on which cells that are naturally present in a patient’s blood can form new heart valve tissue.

  • Article - 06-Nov-2017

    Peptide- and protein-based drugs like those used for treating diabetes, cancer and autoimmune diseases cannot be administered orally. This is because these biomolecules degrade in the gastrointestinal tract, thus preventing them from reaching their target site in the body. Protein- and peptide-base drugs therefore have to be administered by way of injection, which is comparatively complicated and painful. However, a start-up company called Heidelberg Delivery Technologies GmbH has now developed an innovative technology that makes taking medicines as easy as eating gummy bears.

  • Article - 18-Oct-2017

    The fight against acute myeloid leukaemia is a long one. Cancer cells that cause the disease to recur may remain despite initially successful destruction of the tumour with chemotherapy drugs. Now researchers from Tübingen have identified an antibody that could potentially prevent cancer recurrence.

  • Article - 11-Oct-2017

    The causes, signs and symptoms of liver cancer are extremely complex. Investigating them requires the collaboration of many experts across university and regional boundaries. A new transregional research group is now studying the complex overall mechanisms at the cellular, genetic and molecular level in order to develop new concepts and drugs for treating liver and bile duct cancers.

  • Article - 28-Sep-2017

    Repairing herniated discs is a clinical need that has still not been met. When the discomfort becomes unbearable, surgery can be performed and the intervertebral disc is generally removed. However, this can further reduce the patients’ quality of life. Scientists at DITF, in cooperation with the Spanish company NEOS Surgery S.L., have developed a textile-based device for treating herniated discs. The device is a minimally invasive “repair kit” that not only relieves patient suffering, but also ensures that the disc retains its shock absorbing function.

  • Article - 15-Sep-2017

    Infections caused by mosquito-borne Zika viruses during pregnancy can lead to severe brain defects in babies. The European Union has provided funding of around ten million euros for an international research programme on Zika virus infections in which the University Hospital of Heidelberg plays a key role.

  • Article - 04-Sep-2017

    A team of researchers from several EU countries has developed a new drug that stops the progression of hereditary retinal diseases. The project partners founded a company called Mireca Medicines GmbH in the city of Tübingen to bring the drug to market.

  • Article - 28-Aug-2017

    Antibiotic-resistant pathogens are becoming an increasing problem, especially in hospitals. Infected patients must be isolated as soon as possible. However, appropriate methods for testing patients upon admission to hospital and isolating them if necessary are still lacking. A young biotechnology company from Baden-Württemberg called SpinDiag GmbH has developed a cost-effective method for the rapid testing of microbial resistance in normal hospital wards without the need for comprehensive equipment.

  • Article - 22-Aug-2017

    A research team from Freiburg is developing a method for identifying human influenza viruses of animal origin. This could potentially improve measures taken to prevent imminent pandemics. The researchers are working with genetically modified mice. Transgenic mice also play a role in the development of a ’universal’ influenza vaccine.

  • Article - 14-Aug-2017

    Therapeutic success can only be achieved when diagnoses are as precise as possible. Nowadays, genetic analyses can make precise diagnoses for many diseases. And thanks to high-throughput technology, results are available to patients very quickly. Dr. Dr. Saskia Biskup recognised the importance of precision medicine many years ago and went on to found CeGaT GmbH, a company that combines human genetics with high-throughput sequencing. Three subsidiaries have since been created and Biskup, a medical doctor by training, would under no circumstances give up her autonomy for a purely academic career.

  • Article - 08-Aug-2017

    There are many medications for treating central nervous system diseases. However, only a fraction of the active pharmaceutical ingredients actually reaches the site where they are needed. The reason for this is the blood-brain barrier that protects the brain and thus prevents many drugs used to treat neurological diseases from effectively penetrating the brain. Researchers from the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB are part of the international N2B-patch consortium that is developing a drug delivery technology for treating multiple sclerosis that enables the active ingredient to reach the brain directly via the nasal mucosa.

  • Article - 02-Aug-2017

    The German healthcare cost reimbursement system differentiates between in- and outpatient medical products. In an interview with Caroline Ref and Jasmin Dabrowski from BIOPRO Baden-Württemberg, Michael Weißer, Chief Operating Officer of AiM GmbH in Lörrach, gives interesting insights into the reimbursement of medical care products, in particular with regard to the introduction of new and innovative diagnosis and treatment methods.

Website address: https://www.gesundheitsindustrie-bw.de/en/article/news/